市场见解

Here’s how the Medibank (ASX:MPL) share price has performed against the ASX200 in the last 3 months

Here’s how Medibank compares to the Index since 9 August…
The post Here’s how the Medibank (ASX:MPL) share price has performed against the ASX200 in the last 3 months appeared first on The Motley Fool Australia. –

How has the Medibank Private Ltd (ASX: MPL) share price performed against the S&P/ASX 200 Index (ASX: XJO) in the last 3 months? Good question!

The Medibank share price certainly didn’t have a pleasant start to the week today. It’s closed at $3.43 a share, down 1.3% for the day.

But how has it fared over the past 3 months? Well, back on 9 August, Medibank shares closed at a price of $3.41 each. That means Medibank shares have gone almost nowhere over the past 3 months (well, a gain of 0.59%) going off those bookend dates.

But that’s not to say the share price did nothing that whole time. In fact, on 7 September, the company hit a new 52-week high of $3.62 a share. By the back end of October, this private health insurance giant descended as low as $3.32 a share. That’s a difference of around 8.3%.

You can see this visually represented in the graph below:

Medibank Private 3-month share price graph & data | Source: fool.com.au

But, as it turns out, this particular 3 month period has resulted in the Medibank share price going nowhere. That’s just how these things work sometimes. So how did the ASX 200 perform by comparison?

Well, the ASX 200 closed at 7,538.4 points back on 9 August. Today, it finished up at 7,452.2 points, a drop of 1.14% over the same period. Suddenly, Medibank’s anaemic performance over this period doesn’t look quite so bad, seeing it was still a market-beating investment.

Saying that, there was another silver lining for Medibank shareholders during this period. On 30 September, Medibank paid out its final dividend for FY21, a 6.9 cents per share payment, fully franked. This dividend in itself is worth a yield of roughly 2% on today’s pricing, so shareholders had that to bank over the past 3 months as well.

Medibank Private share price snapshot

Whilst Medibank has had a rather uninspiring 3 months, its longer-term performance is far more robust. Year to date, Medibank shares are up a healthy 13.95%, outperforming the ASX 200’s 11.49% performance over the same period. Over the past 12 months, Medibank shares are also up by 26.1%, again beating the ASX 200’s 20%.

At Medibank Private’s closing price of $3.43 today, this ASX 200 company has a market capitalisation of $9.45 billion, with a trailing annual dividend yield of 3.7%.

The post Here’s how the Medibank (ASX:MPL) share price has performed against the ASX200 in the last 3 months appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank Private right now?

Before you consider Medibank Private, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

ASX 200 companies take note – global carbon credit trades soaring

Here are the top 10 ASX shares today

Here are the 3 most heavily traded ASX 200 shares on Monday

AFIC (ASX:AFI) shares have a net tangible asset backing of $7.51 each. What does this mean?

Why has the ANZ (ASX:ANZ) share price dropped 2% today?

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!